Literature DB >> 2991931

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

S Z Salahuddin, P D Markham, M Popovic, M G Sarngadharan, S Orndorff, A Fladagar, A Patel, J Gold, R C Gallo.   

Abstract

Acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) are thought to be caused by human T-cell leukemia/lymphotropic virus type III (HTLV-III). Since the fall of 1982, independent isolates of HTLV-III have been obtained in this laboratory, in collaboration with several clinical groups, from 101 AIDS and ARC patients and healthy donors at risk for AIDS. Most isolates were from peripheral blood T lymphocytes established in cell culture, but some were obtained from bone marrow, lymph node, brain tissue, and cell-free plasma and from cells associated with saliva, cerebrospinal fluid, and semen. Virus was isolated from approximately 50% of AIDS patients, 85% of ARC patients, and 30% of healthy individuals at risk for AIDS. The risk groups included homosexuals, promiscuous heterosexuals, i.v. drug users, recipients of blood or blood products, and spouses and offspring of AIDS patients and others at risk for AIDS. A high correlation was seen between persistent levels of serum antibody and the ability to isolate virus from patient or donor leukocytes. Immunologic and nucleic acid analysis demonstrated that the virus isolates were highly related, although substantial diversity was observed in the restriction enzyme cleavage patterns of those studied in detail. Biological analysis of cells from infected patients and donors as well as from normal peripheral blood mononuclear cells exposed to virus in vitro demonstrated that OKT4/Leu3a+ (helper/inducer) lymphocytes were preferentially infected and were subjected to a characteristic cytopathic effect. The availability of multiple isolates of virus from a number of different patients and donors will greatly facilitate the characterization of HTLV-III and the study of possible biological and/or biochemical variants of the virus responsible for the development of AIDS, ARC, and related diseases.

Entities:  

Mesh:

Year:  1985        PMID: 2991931      PMCID: PMC391156          DOI: 10.1073/pnas.82.16.5530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  A pathogenic retrovirus (HTLV-III) linked to AIDS.

Authors:  S Broder; R C Gallo
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

2.  Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.

Authors:  P M Feorino; V S Kalyanaraman; H W Haverkos; C D Cabradilla; D T Warfield; H W Jaffe; A K Harrison; M S Gottlieb; D Goldfinger; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

3.  Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene.

Authors:  T H Lee; J E Coligan; J G Sodroski; W A Haseltine; S Z Salahuddin; F Wong-Staal; R C Gallo; M Essex
Journal:  Science       Date:  1984-10-05       Impact factor: 47.728

4.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

5.  HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

Authors:  J E Groopman; S Z Salahuddin; M G Sarngadharan; P D Markham; M Gonda; A Sliski; R C Gallo
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

6.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

7.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

8.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

9.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  HTLV-III in cells cultured from semen of two patients with AIDS.

Authors:  D Zagury; J Bernard; J Leibowitch; B Safai; J E Groopman; M Feldman; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

View more
  26 in total

1.  Filtration sizes of human immunodeficiency virus type 1 and surrogate viruses used to test barrier materials.

Authors:  C D Lytle; S C Tondreau; W Truscott; A P Budacz; R K Kuester; L Venegas; R E Schmukler; W H Cyr
Journal:  Appl Environ Microbiol       Date:  1992-02       Impact factor: 4.792

2.  Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques.

Authors:  R Keith Reeves; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

3.  Monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus.

Authors:  L H Gosting; J McClure; E S Dickinson; S M Watanabe; K Shriver; L C Goldstein
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.

Authors:  R Leonard; D Zagury; I Desportes; J Bernard; J F Zagury; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Evidence for different immune responses to HIV in CSF and serum?

Authors:  T Weber; W Büttner; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1987-03-16

6.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency.

Authors:  S Gupta; C E Ribak; S Gollapudi; C H Kim; S Z Salahuddin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

Authors:  J B Jackson; S Y Kwok; J J Sninsky; J S Hopsicker; K J Sannerud; F S Rhame; K Henry; M Simpson; H H Balfour
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

10.  Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.

Authors:  K S Steimer; K W Higgins; M A Powers; J C Stephans; A Gyenes; C George-Nascimento; P A Luciw; P J Barr; R A Hallewell; R Sanchez-Pescador
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.